Roadshow
NeuroSwift Pro
NeuroSwift Pro is an AI-powered clinical decision support system for brain-related disorders. It captures and analyzes eye movement, vestibular signals, and pupillary responses to provide objective biomarkers essential for identifying neurological conditions such as Parkinson’s disease, central vertigo, and post-concussive syndrome. The system integrates advanced AI modules including automatic nystagmus detection, gaze fixation analysis, and pupil tracking. These tools enable clinicians to detect subtle abnormalities that are often missed during routine examinations.
NeuroSwift Pro generates structured reports and visual analytics that support diagnostic reasoning and follow-up monitoring. When combined with AIVertigo, a guided evaluation platform, the system can incorporate symptom-based triage and testing recommendations. This integration improves diagnostic accuracy, streamlines clinical workflows, and enhances decision-making in neurology, otolaryngology, and general practice settings.
- Established 2016
- Company Neurobit Technologies Co., Ltd.
- Telephone 02-2771-0618
- Email info@neurobittech.com
- Address 2F., No. 320, Sec. 4, Zhongxiao E. Rd., Da'an Dist., Taipei City 106433, Taiwan
Neurobit is a biomedical innovation company building intelligent healthcare platforms based on visual physiological signals. By integrating eye movement data, optical measurements, and AI analytics, we develop solutions for clinical decision support, health risk prediction, and patient-centered care.
Our technologies range from neurological and vestibular diagnostics to myopia risk tracking in children and are certified for medical use across multiple regions. Our products are trusted by specialists in neurology, ophthalmology, ENT, family medicine, and preventive healthcare.
With a platform-first approach and deep interdisciplinary expertise, Neurobit is redefining how visual signals drive smarter, faster, and more scalable healthcare.